A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.

Clinical trial NCT02354976 · COMPLETED

Trial details

NCT number: NCT02354976
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-alcoholic Fatty Liver Disease (NAFLD Hypertriglyceridemia

Start date: 2015-09-01
Primary completion: 2016-05-26
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.